Home/Filings/4/0001209191-21-034400
4//SEC Filing

TARNOW MICHAEL M 4

Accession 0001209191-21-034400

CIK 0001582313other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:18 PM ET

Size

15.3 KB

Accession

0001209191-21-034400

Insider Transaction Report

Form 4
Period: 2021-05-18
Transactions
  • Exercise/Conversion

    Common Shares

    2021-05-18$3.87/sh+2,057$7,96171,770 total
  • Exercise/Conversion

    Common Shares

    2021-05-18$3.67/sh+1,028$3,77372,798 total
  • Exercise/Conversion

    Common Shares

    2021-05-18$3.67/sh+5,144$18,87877,942 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-05-182,0570 total
    Exercise: $3.87Exp: 2021-06-30Common Shares (2,057 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-05-181,0280 total
    Exercise: $3.67Exp: 2021-12-31Common Shares (1,028 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-05-185,1440 total
    Exercise: $3.67Exp: 2021-12-31Common Shares (5,144 underlying)
Footnotes (4)
  • [F1]No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of a lock-up agreement executed by the Reporting Person in favor of the underwriters of the Company's public offering in March 2021.
  • [F2]The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
  • [F3]The shares subject to the option fully vested on July 1, 2014.
  • [F4]1/3 of the shares subject to the Option vested on January 1, 2013 (the "First 2012 Vesting Commencement Date") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the First 2012 Vesting Commencement Date over the following 2 years.

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1
  • filerCIK 0001263647

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:18 PM ET
Size
15.3 KB